NURS 6675 Week 11 Final Exam: PMHNP Care Across the
Lifespan II (2026/2027) Comprehensive Assessment
Year: 2026-2027 | Verified Question Count: 100 Questions | 100% VERIFIED
Introduction
This comprehensive exam assessment provides a rigorous, 100-question evaluation designed for
advanced psychiatric-mental health nursing candidates preparing for high-stakes academic and
board certification examinations. Mapped directly to national PMHNP domain blueprints, this
assessment evaluates professional judgment across six core clinical domains: Psychopharmacology,
DSM-5-TR Diagnostic Criteria, Psychotherapy Modalities, Risk Assessment and Suicide Prevention,
Neurobiology of Psychiatric Disorders, and Evidence-Based Treatment Planning Across the
Lifespan. Mastery of these integrated domains ensures that candidates demonstrate the advanced
diagnostic, neurobiological, therapeutic, and psychopharmacologic competence required to deliver
safe, high-quality psychiatric care across diverse clinical settings.
―――――――――――――――――――――――――――――――――――――――――――――――――――――――
Question 1. A 38-year-old patient with treatment-resistant schizophrenia is maintained on
clozapine. The clinician receives a absolute neutrophil count (ANC) result of 950/mm³. According
to the Clozapine Risk Evaluation and Mitigation Strategy (REMS) guidelines, what is the most
appropriate immediate clinical action?
A. Interrupt clozapine therapy immediately, obtain a repeat ANC within 24 hours, and consult
hematology.
B. Continue clozapine at the current dose and recheck the ANC in 14 days.
C. Increase the clozapine dosage by 50 mg/day to stimulate bone marrow production.
D. Switch the patient immediately to high-dose olanzapine without monitoring.
Correct Answer: A. Interrupt clozapine therapy immediately, obtain a repeat ANC within 24
hours, and consult hematology.
Rationale: An ANC between 500/mm³ and 999/mm³ represents moderate neutropenia under Clozapine
REMS guidelines. The mandatory response requires immediate interruption of clozapine therapy, daily
ANC monitoring until ANC returns to >=1000/mm³, and hematology consultation. Continuing therapy or
increasing dosage increases risk of fatal agranulocytosis.
Question 2. A 45-year-old patient diagnosed with Bipolar I Disorder has been taking lithium
carbonate 600 mg twice daily. During a routine follow-up, the patient reports coarse hand tremors,
severe nausea, persistent diarrhea, confusion, and ataxia. Serum lithium level is reported at 2.2
mEq/L. Which clinical intervention is indicated?
A. Instruct the patient to take an extra dose of lithium with food.
B. Withhold lithium immediately, assess fluid and electrolyte status, and initiate emergency medical
evaluation for lithium toxicity.
, C. Reassure the patient that these are expected benign side effects that resolve in 4 weeks.
D. Add hydrochlorothiazide 25 mg daily to enhance renal lithium excretion.
Correct Answer: B. Withhold lithium immediately, assess fluid and electrolyte status, and
initiate emergency medical evaluation for lithium toxicity.
Rationale: Serum lithium levels above 1.5 mEq/L indicate toxicity, and levels exceeding 2.0 mEq/L
cause severe neurological and gastrointestinal symptoms including coarse tremor, ataxia, confusion, and
vomiting. Immediate lithium cessation and emergency medical management (hydration, hemodialysis if
severe) are required. Thiazide diuretics decrease renal clearance and worsen toxicity.
Question 3. When initiating lamotrigine for maintenance therapy in a 29-year-old patient with
Bipolar II Disorder, what titration strategy must the clinician prescribe to minimize the risk of
Stevens-Johnson Syndrome (SJS)?
A. Start at 100 mg daily and double the dose every 3 days.
B. Begin with a loading dose of 200 mg daily for 1 week.
C. Start at 25 mg daily for 2 weeks, then 50 mg daily for 2 weeks, gradually doubling every 1 to 2
weeks.
D. Administer 100 mg twice daily concurrently with valproate.
Correct Answer: C. Start at 25 mg daily for 2 weeks, then 50 mg daily for 2 weeks, gradually
doubling every 1 to 2 weeks.
Rationale: Standard lamotrigine initiation mandates starting at 25 mg daily for 14 days, then 50 mg
daily for 14 days, before incremental increases. Rapid titration significantly increases the incidence of
severe, life-threatening cutaneous reactions including SJS and toxic epidermal necrolysis. Valproate
inhibits lamotrigine metabolism, requiring a 50% dose reduction (12.5 mg daily).
Question 4. A 24-year-old female patient of childbearing potential with Bipolar I Disorder is being
evaluated for mood stabilization. The clinician considers prescribing valproic acid (Depakote).
What critical risk factor must be addressed prior to initiating this agent?
A. Valproic acid induces acute hypertensive crisis when taken with dairy products.
B. Valproic acid causes severe irreversible nephrogenic diabetes insipidus in 80% of young females.
C. Valproic acid is completely safe during all trimesters of pregnancy.
D. Valproic acid carries a severe risk of major neural tube defects (spina bifida) and cognitive
impairment in exposed fetuses.
Correct Answer: D. Valproic acid carries a severe risk of major neural tube defects (spina
bifida) and cognitive impairment in exposed fetuses.
Rationale: Valproic acid carries Black Box Warnings for teratogenicity (neural tube defects such as spina
bifida occurring in 1-2% of pregnancies, plus long-term neurodevelopmental deficits), hepatotoxicity,
and pancreatitis. It should be avoided in females of childbearing potential unless alternative mood
stabilizers are ineffective or tolerated poorly, and effective contraception is mandatory.
Question 5. Which second-generation antipsychotic agent exhibits the highest propensity for
significant weight gain, dyslipidemia, and new-onset Type 2 Diabetes Mellitus?
A. Olanzapine.
, B. Ziprasidone.
C. Aripiprazole.
D. Lurasidone.
Correct Answer: A. Olanzapine.
Rationale: Olanzapine (along with clozapine) carries the highest risk among second-generation
antipsychotics for severe metabolic side effects, including marked weight gain, hypertriglyceridemia,
severe insulin resistance, and Type 2 Diabetes Mellitus. In contrast, ziprasidone, aripiprazole, and
lurasidone are metabolically neutral.
Question 6. A 32-year-old patient with schizophrenia develops intense subjective inner
restlessness, motor agitation, and an inability to sit still 4 days after starting haloperidol 5 mg twice
daily. The clinician diagnoses akathisia. What is the most effective pharmacologic management for
this condition?
A. Increase the haloperidol dosage to 10 mg twice daily.
B. Administer propranolol 10 mg to 20 mg two to three times daily.
C. Prescribe dantrolene sodium 100 mg IV.
D. Initiate lithium carbonate 300 mg three times daily.
Correct Answer: B. Administer propranolol 10 mg to 20 mg two to three times daily.
Rationale: Akathisia is a distressing extrapyramidal symptom characterized by subjective and objective
motor restlessness. Beta-adrenergic blockers such as propranolol are first-line pharmacologic
treatments. Central anticholinergics (benztropine) can also be used, but increasing the antipsychotic dose
exacerbates the condition.
Question 7. What is the primary neurobiological mechanism underlying tardive dyskinesia
following prolonged exposure to dopamine D2 receptor antagonists?
A. Excessive accumulation of acetylcholine in the neuromuscular junction.
B. Irreversible destruction of GABAergic interneurons in the occipital lobe.
C. Acute upregulation and hypersensitivity of dopamine D2 receptors in the nigrostriatal pathway.
D. Depletion of serotonin in the raphe nuclei.
Correct Answer: C. Acute upregulation and hypersensitivity of dopamine D2 receptors in the
nigrostriatal pathway.
Rationale: Tardive dyskinesia results from neuroadaptation following chronic blockade of D2 receptors
in the striatum, leading to D2 receptor upregulation, supersensitivity, and structural changes in
nigrostriatal medium spiny neurons. First-line treatments now include vesicular monoamine transporter
2 (VMAT2) inhibitors like valbenazine and deutetrabenazine.
Question 8. A 50-year-old hospitalized patient receiving high-potency antipsychotics develops
high fever (103.8°F), autonomic instability (fluctuating blood pressure, diaphoresis), severe muscle
rigidity ('lead-pipe'), altered mental status, and elevated serum creatine kinase (CK 12,000 U/L).
What is the priority emergency diagnosis and intervention?
A. Serotonin Syndrome; administer cyproheptadine.
, B. Anticholinergic Toxicity; administer physostigmine.
C. Acute Dystonic Reaction; administer IM diphenhydramine.
D. Neuroleptic Malignant Syndrome (NMS); discontinue offending antipsychotic immediately,
initiate aggressive cooling and hydration, and consider dantrolene or bromocriptine.
Correct Answer: D. Neuroleptic Malignant Syndrome (NMS); discontinue offending
antipsychotic immediately, initiate aggressive cooling and hydration, and consider
dantrolene or bromocriptine.
Rationale: The presentation of hyperthermia, lead-pipe muscle rigidity, autonomic instability, altered
consciousness, and markedly elevated CK is diagnostic for Neuroleptic Malignant Syndrome (NMS).
Immediate discontinuation of all dopaminergic blockers, ICU supportive care, hydration, cooling, and
administration of dantrolene (muscle relaxant) or bromocriptine (dopamine agonist) are required.
Question 9. A patient prescribed phenelzine (an MAOI) presents to the emergency department
with severe throbbing headache, palpitations, neck stiffness, and blood pressure of 210/120 mmHg
after consuming aged cheeses and red wine. What pathophysiological event occurred?
A. Ingestion of exogenous tyramine, which displaces stored norepinephrine into the synaptic cleft
due to MAO-A inhibition.
B. Inhibition of hepatic CYP3A4 enzymes leading to SSRI toxicity.
C. Acute histamine release triggering anaphylactic shock.
D. Direct blockade of beta-1 adrenergic receptors in the myocardium.
Correct Answer: A. Ingestion of exogenous tyramine, which displaces stored norepinephrine
into the synaptic cleft due to MAO-A inhibition.
Rationale: Monoamine oxidase A (MAO-A) degrades tyramine in the gastrointestinal tract and liver.
MAOIs block this breakdown, allowing dietary tyramine (found in aged cheese, wine, cured meats) to
enter systemic circulation and enter presynaptic sympathetic terminals, displacing massive quantities of
stored norepinephrine and causing a life-threatening hypertensive crisis.
Question 10. A 42-year-old patient established on stable doses of clozapine (300 mg/day)
abruptly stops smoking 2 packs of cigarettes per day upon entering a smoke-free facility. Within 5
days, the patient experiences somnolence, hypersalivation, and dizziness. What CYP450 enzyme
dynamic explains this clinical change?
A. Nicotine inhibits CYP2D6; stopping smoking increases clozapine excretion.
B. Polycyclic aromatic hydrocarbons in tobacco smoke induce CYP1A2; cessation removes induction,
causing clozapine plasma levels to rise sharply.
C. Cigarette smoke induces CYP3A4, which permanently destroys clozapine molecules.
D. Smoking cessation alters gastric pH, preventing oral drug absorption.
Correct Answer: B. Polycyclic aromatic hydrocarbons in tobacco smoke induce CYP1A2;
cessation removes induction, causing clozapine plasma levels to rise sharply.
Rationale: Hydrocarbons in tobacco smoke (not nicotine) are potent inducers of the hepatic CYP1A2
enzyme, which metabolizes clozapine and olanzapine. When a patient abruptly stops smoking, CYP1A2
induction resolves, leading to significantly higher clozapine plasma concentrations and potential toxicity
if the dose is not reduced by 30-50%.
Lifespan II (2026/2027) Comprehensive Assessment
Year: 2026-2027 | Verified Question Count: 100 Questions | 100% VERIFIED
Introduction
This comprehensive exam assessment provides a rigorous, 100-question evaluation designed for
advanced psychiatric-mental health nursing candidates preparing for high-stakes academic and
board certification examinations. Mapped directly to national PMHNP domain blueprints, this
assessment evaluates professional judgment across six core clinical domains: Psychopharmacology,
DSM-5-TR Diagnostic Criteria, Psychotherapy Modalities, Risk Assessment and Suicide Prevention,
Neurobiology of Psychiatric Disorders, and Evidence-Based Treatment Planning Across the
Lifespan. Mastery of these integrated domains ensures that candidates demonstrate the advanced
diagnostic, neurobiological, therapeutic, and psychopharmacologic competence required to deliver
safe, high-quality psychiatric care across diverse clinical settings.
―――――――――――――――――――――――――――――――――――――――――――――――――――――――
Question 1. A 38-year-old patient with treatment-resistant schizophrenia is maintained on
clozapine. The clinician receives a absolute neutrophil count (ANC) result of 950/mm³. According
to the Clozapine Risk Evaluation and Mitigation Strategy (REMS) guidelines, what is the most
appropriate immediate clinical action?
A. Interrupt clozapine therapy immediately, obtain a repeat ANC within 24 hours, and consult
hematology.
B. Continue clozapine at the current dose and recheck the ANC in 14 days.
C. Increase the clozapine dosage by 50 mg/day to stimulate bone marrow production.
D. Switch the patient immediately to high-dose olanzapine without monitoring.
Correct Answer: A. Interrupt clozapine therapy immediately, obtain a repeat ANC within 24
hours, and consult hematology.
Rationale: An ANC between 500/mm³ and 999/mm³ represents moderate neutropenia under Clozapine
REMS guidelines. The mandatory response requires immediate interruption of clozapine therapy, daily
ANC monitoring until ANC returns to >=1000/mm³, and hematology consultation. Continuing therapy or
increasing dosage increases risk of fatal agranulocytosis.
Question 2. A 45-year-old patient diagnosed with Bipolar I Disorder has been taking lithium
carbonate 600 mg twice daily. During a routine follow-up, the patient reports coarse hand tremors,
severe nausea, persistent diarrhea, confusion, and ataxia. Serum lithium level is reported at 2.2
mEq/L. Which clinical intervention is indicated?
A. Instruct the patient to take an extra dose of lithium with food.
B. Withhold lithium immediately, assess fluid and electrolyte status, and initiate emergency medical
evaluation for lithium toxicity.
, C. Reassure the patient that these are expected benign side effects that resolve in 4 weeks.
D. Add hydrochlorothiazide 25 mg daily to enhance renal lithium excretion.
Correct Answer: B. Withhold lithium immediately, assess fluid and electrolyte status, and
initiate emergency medical evaluation for lithium toxicity.
Rationale: Serum lithium levels above 1.5 mEq/L indicate toxicity, and levels exceeding 2.0 mEq/L
cause severe neurological and gastrointestinal symptoms including coarse tremor, ataxia, confusion, and
vomiting. Immediate lithium cessation and emergency medical management (hydration, hemodialysis if
severe) are required. Thiazide diuretics decrease renal clearance and worsen toxicity.
Question 3. When initiating lamotrigine for maintenance therapy in a 29-year-old patient with
Bipolar II Disorder, what titration strategy must the clinician prescribe to minimize the risk of
Stevens-Johnson Syndrome (SJS)?
A. Start at 100 mg daily and double the dose every 3 days.
B. Begin with a loading dose of 200 mg daily for 1 week.
C. Start at 25 mg daily for 2 weeks, then 50 mg daily for 2 weeks, gradually doubling every 1 to 2
weeks.
D. Administer 100 mg twice daily concurrently with valproate.
Correct Answer: C. Start at 25 mg daily for 2 weeks, then 50 mg daily for 2 weeks, gradually
doubling every 1 to 2 weeks.
Rationale: Standard lamotrigine initiation mandates starting at 25 mg daily for 14 days, then 50 mg
daily for 14 days, before incremental increases. Rapid titration significantly increases the incidence of
severe, life-threatening cutaneous reactions including SJS and toxic epidermal necrolysis. Valproate
inhibits lamotrigine metabolism, requiring a 50% dose reduction (12.5 mg daily).
Question 4. A 24-year-old female patient of childbearing potential with Bipolar I Disorder is being
evaluated for mood stabilization. The clinician considers prescribing valproic acid (Depakote).
What critical risk factor must be addressed prior to initiating this agent?
A. Valproic acid induces acute hypertensive crisis when taken with dairy products.
B. Valproic acid causes severe irreversible nephrogenic diabetes insipidus in 80% of young females.
C. Valproic acid is completely safe during all trimesters of pregnancy.
D. Valproic acid carries a severe risk of major neural tube defects (spina bifida) and cognitive
impairment in exposed fetuses.
Correct Answer: D. Valproic acid carries a severe risk of major neural tube defects (spina
bifida) and cognitive impairment in exposed fetuses.
Rationale: Valproic acid carries Black Box Warnings for teratogenicity (neural tube defects such as spina
bifida occurring in 1-2% of pregnancies, plus long-term neurodevelopmental deficits), hepatotoxicity,
and pancreatitis. It should be avoided in females of childbearing potential unless alternative mood
stabilizers are ineffective or tolerated poorly, and effective contraception is mandatory.
Question 5. Which second-generation antipsychotic agent exhibits the highest propensity for
significant weight gain, dyslipidemia, and new-onset Type 2 Diabetes Mellitus?
A. Olanzapine.
, B. Ziprasidone.
C. Aripiprazole.
D. Lurasidone.
Correct Answer: A. Olanzapine.
Rationale: Olanzapine (along with clozapine) carries the highest risk among second-generation
antipsychotics for severe metabolic side effects, including marked weight gain, hypertriglyceridemia,
severe insulin resistance, and Type 2 Diabetes Mellitus. In contrast, ziprasidone, aripiprazole, and
lurasidone are metabolically neutral.
Question 6. A 32-year-old patient with schizophrenia develops intense subjective inner
restlessness, motor agitation, and an inability to sit still 4 days after starting haloperidol 5 mg twice
daily. The clinician diagnoses akathisia. What is the most effective pharmacologic management for
this condition?
A. Increase the haloperidol dosage to 10 mg twice daily.
B. Administer propranolol 10 mg to 20 mg two to three times daily.
C. Prescribe dantrolene sodium 100 mg IV.
D. Initiate lithium carbonate 300 mg three times daily.
Correct Answer: B. Administer propranolol 10 mg to 20 mg two to three times daily.
Rationale: Akathisia is a distressing extrapyramidal symptom characterized by subjective and objective
motor restlessness. Beta-adrenergic blockers such as propranolol are first-line pharmacologic
treatments. Central anticholinergics (benztropine) can also be used, but increasing the antipsychotic dose
exacerbates the condition.
Question 7. What is the primary neurobiological mechanism underlying tardive dyskinesia
following prolonged exposure to dopamine D2 receptor antagonists?
A. Excessive accumulation of acetylcholine in the neuromuscular junction.
B. Irreversible destruction of GABAergic interneurons in the occipital lobe.
C. Acute upregulation and hypersensitivity of dopamine D2 receptors in the nigrostriatal pathway.
D. Depletion of serotonin in the raphe nuclei.
Correct Answer: C. Acute upregulation and hypersensitivity of dopamine D2 receptors in the
nigrostriatal pathway.
Rationale: Tardive dyskinesia results from neuroadaptation following chronic blockade of D2 receptors
in the striatum, leading to D2 receptor upregulation, supersensitivity, and structural changes in
nigrostriatal medium spiny neurons. First-line treatments now include vesicular monoamine transporter
2 (VMAT2) inhibitors like valbenazine and deutetrabenazine.
Question 8. A 50-year-old hospitalized patient receiving high-potency antipsychotics develops
high fever (103.8°F), autonomic instability (fluctuating blood pressure, diaphoresis), severe muscle
rigidity ('lead-pipe'), altered mental status, and elevated serum creatine kinase (CK 12,000 U/L).
What is the priority emergency diagnosis and intervention?
A. Serotonin Syndrome; administer cyproheptadine.
, B. Anticholinergic Toxicity; administer physostigmine.
C. Acute Dystonic Reaction; administer IM diphenhydramine.
D. Neuroleptic Malignant Syndrome (NMS); discontinue offending antipsychotic immediately,
initiate aggressive cooling and hydration, and consider dantrolene or bromocriptine.
Correct Answer: D. Neuroleptic Malignant Syndrome (NMS); discontinue offending
antipsychotic immediately, initiate aggressive cooling and hydration, and consider
dantrolene or bromocriptine.
Rationale: The presentation of hyperthermia, lead-pipe muscle rigidity, autonomic instability, altered
consciousness, and markedly elevated CK is diagnostic for Neuroleptic Malignant Syndrome (NMS).
Immediate discontinuation of all dopaminergic blockers, ICU supportive care, hydration, cooling, and
administration of dantrolene (muscle relaxant) or bromocriptine (dopamine agonist) are required.
Question 9. A patient prescribed phenelzine (an MAOI) presents to the emergency department
with severe throbbing headache, palpitations, neck stiffness, and blood pressure of 210/120 mmHg
after consuming aged cheeses and red wine. What pathophysiological event occurred?
A. Ingestion of exogenous tyramine, which displaces stored norepinephrine into the synaptic cleft
due to MAO-A inhibition.
B. Inhibition of hepatic CYP3A4 enzymes leading to SSRI toxicity.
C. Acute histamine release triggering anaphylactic shock.
D. Direct blockade of beta-1 adrenergic receptors in the myocardium.
Correct Answer: A. Ingestion of exogenous tyramine, which displaces stored norepinephrine
into the synaptic cleft due to MAO-A inhibition.
Rationale: Monoamine oxidase A (MAO-A) degrades tyramine in the gastrointestinal tract and liver.
MAOIs block this breakdown, allowing dietary tyramine (found in aged cheese, wine, cured meats) to
enter systemic circulation and enter presynaptic sympathetic terminals, displacing massive quantities of
stored norepinephrine and causing a life-threatening hypertensive crisis.
Question 10. A 42-year-old patient established on stable doses of clozapine (300 mg/day)
abruptly stops smoking 2 packs of cigarettes per day upon entering a smoke-free facility. Within 5
days, the patient experiences somnolence, hypersalivation, and dizziness. What CYP450 enzyme
dynamic explains this clinical change?
A. Nicotine inhibits CYP2D6; stopping smoking increases clozapine excretion.
B. Polycyclic aromatic hydrocarbons in tobacco smoke induce CYP1A2; cessation removes induction,
causing clozapine plasma levels to rise sharply.
C. Cigarette smoke induces CYP3A4, which permanently destroys clozapine molecules.
D. Smoking cessation alters gastric pH, preventing oral drug absorption.
Correct Answer: B. Polycyclic aromatic hydrocarbons in tobacco smoke induce CYP1A2;
cessation removes induction, causing clozapine plasma levels to rise sharply.
Rationale: Hydrocarbons in tobacco smoke (not nicotine) are potent inducers of the hepatic CYP1A2
enzyme, which metabolizes clozapine and olanzapine. When a patient abruptly stops smoking, CYP1A2
induction resolves, leading to significantly higher clozapine plasma concentrations and potential toxicity
if the dose is not reduced by 30-50%.
